Stockscreener 앱 받기
2.42
6.92%
-0.18
시간 외 거래:
2.50
0.08
+3.31%
전일 마감가:
$2.60
열려 있는:
$2.63
하루 거래량:
647.09K
Relative Volume:
1.30
시가총액:
$187.18M
수익:
-
순이익/손실:
-
주가수익비율:
2.1786
EPS:
1.1108
순현금흐름:
-
1주 성능:
-2.42%
1개월 성능:
+19.21%
6개월 성능:
-82.02%
1년 성능:
-82.02%
1일 변동 폭
$2.34
$2.63
1주일 범위
$2.0223
$2.71
52주 변동 폭
$1.885
$2.71
Accendra Health Inc Stock (ACH) Company Profile
명칭
Accendra Health Inc
전화
(804) 277-4304
주소
10900 NUCKOLS ROAD, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
2.42 | 201.10M | 0 | 0 | 0 | 0.00 |
|
MCK
Mckesson Corporation
|
974.45 | 117.98B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
366.65 | 70.62B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
227.13 | 53.22B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
81.47 | 9.64B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.40 | 1.10B | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-07-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-12 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | 재개 | Citigroup | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-30 | 재개 | JP Morgan | Underweight |
| 2022-03-23 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2021-04-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-03-08 | 업그레이드 | Goldman | Sell → Buy |
| 2020-12-17 | 업그레이드 | UBS | Neutral → Buy |
| 2020-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-01-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-11-15 | 업그레이드 | CLSA | Underperform → Outperform |
| 2019-09-06 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-10 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-03 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-01-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-15 | 업그레이드 | CLSA | Underperform → Outperform |
| 2018-12-14 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-09-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | 다운그레이드 | CLSA | Outperform → Sell |
| 2018-04-10 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | 업그레이드 | Goldman | Sell → Neutral |
| 2017-11-02 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2016-03-24 | 업그레이드 | Goldman | Sell → Neutral |
| 2015-12-07 | 다운그레이드 | Goldman | Neutral → Sell |
| 2015-08-31 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | 개시 | HSBC Securities | Underweight |
| 2009-08-05 | 업그레이드 | Citigroup | Sell → Buy |
| 2008-12-01 | 다운그레이드 | HSBC Securities | Neutral → Underweight |
모두보기
Accendra Health Inc 주식(ACH)의 최신 뉴스
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
MSN Money - MSN
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
Total debt per share of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Gree Says Won’t Hike Air-Con Prices, Swap Copper for Aluminum Despite Metal’s Surging Cost - Yicai Global
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Total revenue of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
China Metals & Mining Industry Report 2025, Profiles of Jiangxi Copper, China Shenhua Energy Co, Zijin Mining Group, Aluminum Corp of China - Yahoo Finance
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
"Post-70s" Lu Dongliang became Vice Governor of Shanxi Province before becoming Chairman of Aluminum Corporation of China - Shanghai Metals Market
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Chalco’s Stock Tests Investor Nerves As Aluminum Cycle Turns: Is The Worst Finally Priced In? - AD HOC NEWS
Accendra Health Inc (ACH) 재무 분석
Accendra Health Inc (ACH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.59%
0.56%
자본화:
|
볼륨(24시간):